Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor superfamily. The activation of PPARs by their specific ligands is regarded as one of the promising strategies to inhibit cancer cell growth. However, recent clinical trials targeting several common cancers showed...
Main Authors: | Masahito Shimizu, Hisataka Moriwaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/181047 |
Similar Items
-
A Role for Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Therapeutic Strategy Targeting Phosphorylated Retinoid X Receptor-α
by: Hiroyasu Sakai, et al.
Published: (2014-07-01) -
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
by: Masahito Shimizu, et al.
Published: (2012-01-01) -
The effect of acyclic retinoid on the metabolomic profiles of hepatocytes and hepatocellular carcinoma cells.
by: Xian-Yang Qin, et al.
Published: (2013-01-01) -
Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
by: Abhita Malaviya, et al.
Published: (2014-01-01) -
Effects of PPARγ Ligands on Leukemia
by: Yoko Tabe, et al.
Published: (2012-01-01)